38115011|t|TNFR1 signaling converging on FGF14 controls neuronal hyperactivity and sickness behavior in experimental cerebral malaria.
38115011|a|BACKGROUND: Excess tumor necrosis factor (TNF) is implicated in the pathogenesis of hyperinflammatory experimental cerebral malaria (eCM), including gliosis, increased levels of fibrin(ogen) in the brain, behavioral changes, and mortality. However, the role of TNF in eCM within the brain parenchyma, particularly directly on neurons, remains underdefined. Here, we investigate electrophysiological consequences of eCM on neuronal excitability and cell signaling mechanisms that contribute to observed phenotypes. METHODS: The split-luciferase complementation assay (LCA) was used to investigate cell signaling mechanisms downstream of tumor necrosis factor receptor 1 (TNFR1) that could contribute to changes in neuronal excitability in eCM. Whole-cell patch-clamp electrophysiology was performed in brain slices from eCM mice to elucidate consequences of infection on CA1 pyramidal neuron excitability and cell signaling mechanisms that contribute to observed phenotypes. Involvement of identified signaling molecules in mediating behavioral changes and sickness behavior observed in eCM were investigated in vivo using genetic silencing. RESULTS: Exploring signaling mechanisms that underlie TNF-induced effects on neuronal excitability, we found that the complex assembly of fibroblast growth factor 14 (FGF14) and the voltage-gated Na+ (Nav) channel 1.6 (Nav1.6) is increased upon tumor necrosis factor receptor 1 (TNFR1) stimulation via Janus Kinase 2 (JAK2). On account of the dependency of hyperinflammatory experimental cerebral malaria (eCM) on TNF, we performed patch-clamp studies in slices from eCM mice and showed that Plasmodium chabaudi infection augments Nav1.6 channel conductance of CA1 pyramidal neurons through the TNFR1-JAK2-FGF14-Nav1.6 signaling network, which leads to hyperexcitability. Hyperexcitability of CA1 pyramidal neurons caused by infection was mitigated via an anti-TNF antibody and genetic silencing of FGF14 in CA1. Furthermore, knockdown of FGF14 in CA1 reduced sickness behavior caused by infection. CONCLUSIONS: FGF14 may represent a therapeutic target for mitigating consequences of TNF-mediated neuroinflammation.
38115011	0	5	TNFR1	Gene	21937
38115011	30	35	FGF14	Gene	14169
38115011	45	67	neuronal hyperactivity	Disease	MESH:D001289
38115011	106	122	cerebral malaria	Disease	MESH:D016779
38115011	143	164	tumor necrosis factor	Gene	21926
38115011	166	169	TNF	Gene	21926
38115011	208	225	hyperinflammatory	Disease	
38115011	239	255	cerebral malaria	Disease	MESH:D016779
38115011	257	260	eCM	Disease	MESH:D016779
38115011	273	280	gliosis	Disease	MESH:D005911
38115011	309	313	ogen	Chemical	MESH:C009927
38115011	385	388	TNF	Gene	21926
38115011	392	395	eCM	Disease	MESH:D016779
38115011	539	542	eCM	Disease	MESH:D016779
38115011	760	792	tumor necrosis factor receptor 1	Gene	21937
38115011	794	799	TNFR1	Gene	21937
38115011	862	865	eCM	Disease	MESH:D016779
38115011	943	946	eCM	Disease	MESH:D016779
38115011	947	951	mice	Species	10090
38115011	981	990	infection	Disease	MESH:D007239
38115011	994	997	CA1	Species	5807
38115011	1210	1213	eCM	Disease	MESH:D016779
38115011	1319	1322	TNF	Gene	21926
38115011	1403	1430	fibroblast growth factor 14	Gene	14169
38115011	1432	1437	FGF14	Gene	14169
38115011	1484	1490	Nav1.6	Gene	20273
38115011	1510	1542	tumor necrosis factor receptor 1	Gene	21937
38115011	1544	1549	TNFR1	Gene	21937
38115011	1567	1581	Janus Kinase 2	Gene	16452
38115011	1583	1587	JAK2	Gene	16452
38115011	1622	1639	hyperinflammatory	Disease	
38115011	1653	1669	cerebral malaria	Disease	MESH:D016779
38115011	1671	1674	eCM	Disease	MESH:D016779
38115011	1679	1682	TNF	Gene	21926
38115011	1732	1735	eCM	Disease	MESH:D016779
38115011	1736	1740	mice	Species	10090
38115011	1796	1802	Nav1.6	Gene	20273
38115011	1826	1829	CA1	Species	5807
38115011	1860	1865	TNFR1	Gene	21937
38115011	1866	1870	JAK2	Gene	16452
38115011	1871	1876	FGF14	Gene	14169
38115011	1877	1883	Nav1.6	Gene	20273
38115011	1918	1935	hyperexcitability	Disease	
38115011	1937	1954	Hyperexcitability	Disease	
38115011	1958	1961	CA1	Species	5807
38115011	1990	1999	infection	Disease	MESH:D007239
38115011	2026	2029	TNF	Gene	21926
38115011	2064	2069	FGF14	Gene	14169
38115011	2073	2076	CA1	Species	5807
38115011	2104	2109	FGF14	Gene	14169
38115011	2113	2116	CA1	Species	5807
38115011	2153	2162	infection	Disease	MESH:D007239
38115011	2177	2182	FGF14	Gene	14169
38115011	2249	2252	TNF	Gene	21926
38115011	2262	2279	neuroinflammation	Disease	MESH:D000090862
38115011	Association	MESH:D001289	21937
38115011	Association	14169	16452
38115011	Association	MESH:D001289	14169
38115011	Association	MESH:D000090862	14169
38115011	Association	MESH:D007239	14169
38115011	Association	MESH:D016779	21937
38115011	Association	16452	21937
38115011	Association	MESH:D005911	21926
38115011	Association	MESH:D016779	14169
38115011	Association	20273	21937
38115011	Association	MESH:D016779	20273
38115011	Association	MESH:D016779	21926
38115011	Association	14169	21937
38115011	Association	14169	20273
38115011	Association	MESH:D000090862	21926

